219 related articles for article (PubMed ID: 20659505)
1. Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model.
Sharma A; Bangari DS; Tandon M; Hogenesch H; Mittal SK
Virus Res; 2010 Oct; 153(1):134-42. PubMed ID: 20659505
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.
Sharma A; Bangari DS; Tandon M; Pandey A; HogenEsch H; Mittal SK
Virology; 2009 Mar; 386(1):44-54. PubMed ID: 19211122
[TBL] [Abstract][Full Text] [Related]
3. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
Moffatt S; Hays J; HogenEsch H; Mittal SK
Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
[TBL] [Abstract][Full Text] [Related]
4. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture.
Bangari DS; Shukla S; Mittal SK
Biochem Biophys Res Commun; 2005 Feb; 327(3):960-6. PubMed ID: 15649439
[TBL] [Abstract][Full Text] [Related]
5. Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer.
Tandon M; Sharma A; Vemula SV; Bangari DS; Mittal SK
Virus Res; 2012 Jan; 163(1):202-11. PubMed ID: 21971215
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.
Sharma A; Tandon M; Ahi YS; Bangari DS; Vemulapalli R; Mittal SK
Gene Ther; 2010 May; 17(5):634-42. PubMed ID: 20164856
[TBL] [Abstract][Full Text] [Related]
7. Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.
Sharma A; Bangari DS; Vemula SV; Mittal SK
Virus Res; 2011 Nov; 161(2):181-7. PubMed ID: 21864589
[TBL] [Abstract][Full Text] [Related]
8. Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3.
Bangari DS; Sharma A; Mittal SK
Biochem Biophys Res Commun; 2005 Jun; 331(4):1478-84. PubMed ID: 15883040
[TBL] [Abstract][Full Text] [Related]
9. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors.
Liu Q; Zaiss AK; Colarusso P; Patel K; Haljan G; Wickham TJ; Muruve DA
Hum Gene Ther; 2003 May; 14(7):627-43. PubMed ID: 12804145
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
[TBL] [Abstract][Full Text] [Related]
11. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors.
Shayakhmetov DM; Li ZY; Ni S; Lieber A
J Virol; 2004 May; 78(10):5368-81. PubMed ID: 15113916
[TBL] [Abstract][Full Text] [Related]
12. Current strategies and future directions for eluding adenoviral vector immunity.
Bangari DS; Mittal SK
Curr Gene Ther; 2006 Apr; 6(2):215-26. PubMed ID: 16611043
[TBL] [Abstract][Full Text] [Related]
13. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.
Lieber A; He CY; Meuse L; Schowalter D; Kirillova I; Winther B; Kay MA
J Virol; 1997 Nov; 71(11):8798-807. PubMed ID: 9343240
[TBL] [Abstract][Full Text] [Related]
14. Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors.
Shayakhmetov DM; Li ZY; Ni S; Lieber A
J Immunol; 2005 Jun; 174(11):7310-9. PubMed ID: 15905578
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo.
Appledorn DM; Patial S; McBride A; Godbehere S; Van Rooijen N; Parameswaran N; Amalfitano A
J Immunol; 2008 Aug; 181(3):2134-44. PubMed ID: 18641352
[TBL] [Abstract][Full Text] [Related]
16. Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin.
Bangari DS; Mittal SK
Virology; 2005 Feb; 332(1):157-66. PubMed ID: 15661148
[TBL] [Abstract][Full Text] [Related]
17. Fiber-modified adenovirus vectors decrease liver toxicity through reduced IL-6 production.
Koizumi N; Yamaguchi T; Kawabata K; Sakurai F; Sasaki T; Watanabe Y; Hayakawa T; Mizuguchi H
J Immunol; 2007 Feb; 178(3):1767-73. PubMed ID: 17237426
[TBL] [Abstract][Full Text] [Related]
18. Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus.
Singh N; Pandey A; Jayashankar L; Mittal SK
Mol Ther; 2008 May; 16(5):965-71. PubMed ID: 18301400
[TBL] [Abstract][Full Text] [Related]
19. Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver.
Smith JS; Xu Z; Tian J; Stevenson SC; Byrnes AP
Hum Gene Ther; 2008 May; 19(5):547-54. PubMed ID: 18447633
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral vector immunity: its implications and circumvention strategies.
Ahi YS; Bangari DS; Mittal SK
Curr Gene Ther; 2011 Aug; 11(4):307-20. PubMed ID: 21453277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
